# IRulya Therapeutics Inc.: Form 8-K, filed Apr 28, 2026

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: 8-K
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 16:30 ET
- Period: 2026-04-27
- Accession: 0001193125-26-187243
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000119312526187243/d623526d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000119312526187243/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000119312526187243/d623526d8k.htm

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-187243. Last ingested by Listed: Nov 5, 2026, 16:02 ET. No prices; not investment advice.